Advent International’s $405 Million Sale of its interest in Fleury S.A.

Lobo de Rizzo advised on the deal

Advent International finalized the sale of its interest in the medical services company’s capital.

Advent has been a shareholder of Fleury since September 2015, when it acquired 13% of the lab chain for R$400 million.

Advent International Corporation is a venture capital and private equity firm specializing in seed/ startup, early venture, emerging growth, mature, mid venture, public-to-private transactions, recapitalizations, late venture, later stage, growth equity, leveraged buyouts, industry consolidation, acquisitions, middle and upper middle market buyouts, management buyouts, turnaround, buyins, company succession, international expansion, cross-border transactions, strategic repositioning, recapitalization, and buy and builds, carve-outs, undercapitalized state-owned and family businesses. The firm, led by Peter A. Brooke, Cédric Chateau, Eileen Sivolella, Jarlyth Hancock Gibson and James Westra is based in Boston.

Fleury S.A. operates labs that offer medical testing services in the states of Sao Paulo, Rio de Janeiro, Bahia, Pernambuco, Parana, Rio Grande do Sul and Federal District of Brasilia.

Lobo de Rizzo advised Advent International with Rodrigo Millar de Castro Guerra (Picture) Leonardo Diogo Batista, Gisele Esteves Guedes and Joice Nogueira Dolse.

Involved fees earner: Rodrigo Millar de Castro Guerra – Lobo & de Rizzo; Leonardo Diogo Batista – Lobo & de Rizzo;

Law Firms: Lobo & de Rizzo;

Clients: Advent International;


Author: Ambrogio Visconti.